
Statement by Commissioner Kyriakides on the review by the European Medicines Agency of the AstraZeneca COVID-19 vaccine
Published on April 23, 2021
European Commission Statement Brussels, 23 Apr 2021 Following a formal request by the European Commission, the European Medicines Agency has reviewed additional vaccination and epidemiological data submitted by Member States in relation to the AstraZeneca vaccine.
